FNY Partners Fund’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

FNY Partners Fund’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,000	Closed	-$76K	–	1544
2017 Q1	$76K	Buy	+16,000	New	+$86.9K	0.01%	595

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

FNY Partners Fund's OSIR Position: Q2 2017 in Review

FNY Partners Fund sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 16,000 shares — an estimated $76K sold.

FNY Partners Fund first reported a position in OSIR in Q1 2017 and held it in 1 quarter. The position peaked at $76K in Q1 2017. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

FNY Partners Fund reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 16,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $76K.
FNY Partners Fund first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Osiris Therapeutics, Inc. Common Stock position peaked at $76K in Q1 2017.
3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.